# Post-stroke Epilepsy: Primary Prophylaxis Study

> **NCT04858841** · NA · UNKNOWN · sponsor: **National Cheng Kung University** · enrollment: 180 (estimated)

## Conditions studied

- Middle Cerebral Artery Stroke

## Interventions

- **DRUG:** Levetiracetam Oral Product
- **DRUG:** Perampanel Oral Product
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04858841
- **Lead sponsor:** National Cheng Kung University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2021-04-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04858841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04858841, "Post-stroke Epilepsy: Primary Prophylaxis Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04858841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*